evoke trial semaglutide Misses Mark for Alzheimer Disease in Trials Novo Nordisk announces topline results

Obes Surg 2020

Obesity specialists agree that GLP1 medications are a powerful tool for weight loss

All factors are assessed by a trial clinician before and during participation

However, this doesnt mean your body needs less water

Retatrutide, on the other hand, has demonstrated more dramatic weight loss in trials

Disclosures: Rohit Loomba, MD, is a consultant or advisory board member for Aardvark Therapeutics, Altimmune, Anylam/Regeneron, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Bristol-Myer Squibb, CohBar, Eli Lilly, Galmed, Gilead, Glympse bio, Hightide, Inipharma, Intercept, Inventiva, Ionis, Janssen Inc., Madrigal, Metacrine, Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Merck, Pfizer, Sagimet, Theratechnologies, 89 bio, Terns Pharmaceuticals and Viking Therapeutics